Evidence map›Paper›PMID 39097973›Full record

ArticleCancer communications (London, England)2024

4-1BB transcriptomic expression patterns across malignancies: Implications for clinical trials of 4-1BB agonists.

Yuji Uehara, Shumei Kato, Daisuke Nishizaki, Hirotaka Miyashita, Suzanna Lee, Mary K Nesline, Sarabjot Pabla, Jeffrey M Conroy, Paul DePietro, Heidi Ko and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer communications (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yuji UeharaDepartment of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8047-8730
Shumei KatoCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California, United States.
Daisuke NishizakiCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California, United States.
Hirotaka MiyashitaDartmouth Cancer Center, Hematology and Medical Oncology, Lebanon, New Hampshire, United States.
Suzanna LeeCenter for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, University of California San Diego, Moores Cancer Center, La Jolla, California, United States.
Mary K NeslineLabcorp Oncology, Durham, North Carolina, United States.
Sarabjot PablaOmniSeq Incorporation, Buffalo, New York, United States.
Jeffrey M ConroyOmniSeq Incorporation, Buffalo, New York, United States.
Paul DePietroOmniSeq Incorporation, Buffalo, New York, United States.
Heidi KoLabcorp Oncology, Durham, North Carolina, United States.
Jason K SicklickDivision of Surgical Oncology, Department of Surgery, Center for Personalized Cancer Therapy, University of California San Diego, La Jolla, California, United States.
Razelle KurzrockMedical College of Wisconsin Cancer Center and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI PRIMO N. LARA · 2014 to 2026
$152.1M
Medical College of Wisconsin Lead Academic Participating Site RenewalUG1CA233198 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI William H Bradley, Elizabeth M Gore · 2019 to 2026
$5.0M
NCI NIH HHS U10 CA180888NCI NIH HHS UG1 CA233198NIH HHS 5U01CA180888-08NIH HHS 5UG1CA233198-05
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39097973
PMCPMC11483270

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.